Article thumbnail

Patterns, trends and sex differences in HIV/AIDS reported mortality in Latin American countries: 1996-2007

By Monica Alonso Gonzalez, Luise Martin, Sergio Munoz and Jerry O Jacobson
Topics: Research Article
Publisher: BioMed Central
OAI identifier: oai:pubmedcentral.nih.gov:3173348
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. A life course approach to patterns and trends in modern Latin American sexual behavior. J Acquir Immune Defic Syndr 2009, 51(Suppl 1):S4-S12.
  2. (2008). A: Evolución y situación epidemiológica de la infección por virus de inmunodeficiencia humana y síndrome de inmunodeficiencia adquirida en Chile. Rev Chil Infect
  3. (2009). AIDS Epidemic Update 2009. Geneva: Joint United Nations Programme on HIV/AIDS;
  4. (2005). AIDS in Latin America.
  5. (2008). al: Longterm immunologic response to antiretroviral therapy in low-income countries: a collaborative analysis of prospective studies.
  6. (2009). al: Temporal changes in causes of death among
  7. (2005). Causes of the decline in AIDS deaths, United States, 1995-2002: prevention, treatment or both?
  8. Centers for Disease Control and Prevention:
  9. (2009). Claudín: Universal access, six years results
  10. (1998). Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection.
  11. (2010). Department of Health and Human Services CfDCaP.
  12. (2006). Economic impact of antiretroviral therapy prescription decisions in the context of rapid scaling-up of access to treatment: lessons from Mexico. AIDS
  13. El sida en Mexico en el año
  14. (2008). Elzi L: Antiretroviral therapy of late presenters with advanced HIV disease.
  15. (2008). et al: Changes in the risk of death after HIV seroconversion compared with mortality in the general population. JAMA
  16. (2003). et al: Decline in the AIDS and death rates in the EuroSIDA study: an observational study. Lancet
  17. (2008). et al: Determinants of Treatment Access in a Population-based Cohort of HIVpositive Men and Women Living in Argentina.
  18. (2003). et al: Effectiveness of highly active antiretroviral therapy in Spanish cohorts of HIV seroconverters: differences by transmission category. AIDS
  19. (1998). et al: Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection duration. Multicenter AIDS Cohort Study Investigators. JAMA
  20. (1992). et al: Impact of HIV infection on mortality and accuracy of AIDS reporting on death certificates.
  21. (2006). et al: Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. Lancet
  22. (2008). et al: Population-level effect of HIV on adult mortality and early evidence of reversal after introduction of antiretroviral therapy in Malawi. Lancet
  23. (2009). et al: Regional disparities in HIV-related deaths and access to HAART: evidence from a province-wide universal healthcare system. Cape Town, South Africa;
  24. (2006). et al: Situación del VIH/SIDA y respuesta a la epidemia. Washington, DC: Banco Internacional de Reconstrucción y Fomento/Banco Mundial;
  25. (2009). et al: Survival after AIDS diagnosis in Italy, 1999-2006: a population-based study. J Acquir Immune Defic Syndr
  26. (1986). et al: Survival of AIDS patients using two case definitions, Rio de Janeiro,
  27. (2008). Gender, sex, and HIV: how well are we addressing the imbalance? Curr Opin HIV AIDS
  28. (2008). Health Organization: Health Situation in the Americas: Basic Indicators
  29. Health Organization: Toward Universal Access to HIV Prevention, Care, and Treatment. 3 by 5 Report for the Americas Washington DC:
  30. (2006). Health Statistics from the Americas,
  31. (2003). Hernandez-Tepechin G: El SIDA en las mujeres: logros y asignaturas pendientes. Perinatol Reprod Hum
  32. (2008). HIV in older adults. Geriatrics
  33. (2004). HIV infection and advanced age emerging epidemiological, clinical, and management issues. Ageing Res Rev
  34. (2008). Holodniy M: HIV infection in the elderly. Clin Interv Aging
  35. (2000). La respuesta mexicana al sida: Mejores practicas. Mexico City: Instituto Nacional de Salud Publica de Mexico;
  36. (2007). Lescano A: Nuevas evidencias en VIH -Perú. Lima: Universidad Peruana Cayetano Heredia; Organización Panamericana de la Salud;
  37. (2006). María-Paz León-Bratti: Efecto de la terapia antirretroviral en la rehospitalización por enfermedad oportunista en Costa Rica. Acta méd.costarric
  38. (1984). MJ: Changing mortality rates and causes of death for HIV-infected individuals living in
  39. (2009). ML: Adult mortality and antiretroviral treatment roll-out in rural KwaZuluNatal, South Africa. Bull World Health Organ
  40. (2009). Mortality during the first year of potent antiretroviral therapy in HIV-1-infected patients in 7 sites throughout Latin America and the Caribbean. J Acquir Immune Defic Syndr
  41. (2009). Organization, UNAIDS, UNICEF: Towards universal access: scaling up priority HIV/AIDS interventions in the health sector: progress report
  42. (2006). Organization: Progress on global access to HIV antiretroviral therapy: a report on “3b y5 ” and beyond,
  43. (2009). Organization. Global health risks: Mortality and burden of disease attributable to selected major risks. Geneva: World Health Organization;
  44. (2009). Paying the price for late starts and early stops: racial and sex disparities in HIV-related mortality. Clin Infect Dis
  45. (2002). Plan Nacional sobre SIDA: VIH y sida en España. Situación epidemiológica 2001. Madrid: Ministerio de Sanidad y Consumo;
  46. Precoz tratamiento antirretroviral logra reducir la mortalidad por sida.
  47. (2008). Programa Municipal de Sida y el Sistema Municipal de Epidemiología: Boletín Epidemiológico Municipal de VIH/SIDA.
  48. (2005). Racial and gender disparities in receipt of highly active antiretroviral therapy persist in a multistate sample of HIV patients in 2001. J Acquir Immune Defic Syndr
  49. (2009). Salud de Argentina: Boletín sobre el VIH-SIDA en la Argentina: Año XII - número 26 - noviembre de 2009. [Año XII - número 26].
  50. (1984). Salud de Chile: Situación epidemiológica de VIH/SIDA,
  51. (2008). Sánchez K Sánchez: Mortality caused by AIDS in Mexico: an analysis of future trends and projections.
  52. (2009). Social position, gender role, and treatment adherence among Colombian women living with HIV/AIDS: social determinants of health approach. Rev Panam Salud Publica
  53. (2002). Status of the HIV/AIDS epidemic and methods to monitor it in the Latin America and Caribbean region. AIDS
  54. (2010). Strategies to reduce early morbidity and mortality in adults receiving antiretroviral therapy in resource-limited settings. Curr Opin HIV AIDS
  55. (2000). Survival after introduction of HAART in people with known duration of HIV1 infection:
  56. (2005). Szwarcwald CL: Regional patterns of the temporal evolution of the AIDS epidemic in Brazil following the introduction of antiretroviral therapy.
  57. (1996). The ART-LINC Collaboration of the International Databases to Evaluate AIDS (IeDEA): Antiretroviral therapy in resource-limited settings
  58. (2007). UNICEF: Towards universal access: scaling up priority HIV/AIDS interventions in the health sector. Progress Report 2007.Edited by: World Health Organization. Geneva, World Health Organization;
  59. (1988). Víctor Tovar-Guzmán, Carlos del Río: AIDS mortality trends in Mexico,